SCHEMBL15062363

SCHEMBL15062363

O=C(NCCOCCOCCOCCOCCOCCO)C(F)(F)F

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ POLB P06746 1/20 0.52
▸ MEN1 O00255 4/20 0.50
▸ KMT2A Q03164 4/20 0.50
▸ CA3 P07451 2/20 0.46
▸ CA5A P35218 2/20 0.46
▸ CA5B Q9Y2D0 2/20 0.46
▸ CA14 Q9ULX7 2/20 0.46
▸ CA2 P00918 2/20 0.46
▸ CA12 O43570 1/20 0.46
▸ CA4 P22748 1/20 0.46
▸ CA6 P23280 1/20 0.46
▸ CA7 P43166 1/20 0.46
▸ CA9 Q16790 1/20 0.46
▸ EPHX1 P07099 1/20 0.43
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ATG4B Q9Y4P1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3230281 1.00 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL24243983 1.00 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL3219761 1.00 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL2777997 0.98 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL38654908 0.90 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL20067631 0.87 CA3 (0.59) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL21224801 0.85 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL16359229 0.83 EPHX1 (0.55) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL12116757 0.83 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1POLBMEN1KMT2A
SCHEMBL24793189 0.83 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2797946-B1 SIALIC ACID DIMERS BROSSMER REINHARD (DE) 2016-05-04 — — EP disclosed
US-9260467-B2 Sialic acid dimers BROSSMER REINHARD (DE) 2016-02-16 — — US disclosed
US-20150005245-A1 Sialic Acid Dimers BROSSMER REINHARD (DE) 2015-01-01 — — US disclosed
EP-2797946-A1 SIALIC ACID DIMERS Brossmer, Reinhard (DE) 2014-11-05 — — EP disclosed
WO-2013097942-A1 SIALIC ACID DIMERS BROSSMER REINHARD (DE) 2013-07-04 — — WO disclosed
EP-2610263-A1 Sialic acid dimers Brossmer, Reinhard (DE) 2013-07-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005245-A1 Sialic Acid Dimers SIGLEC9, SIGLEC7, NEU2 SMN1; SMN2 1653/4885ALDH1A1 284/4885POLB 4809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback